Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Exocell granted U.S. patent for A717

June 28, 1996

Sankyo to file NDA for Noscal

June 28, 1996

HemAssist to enter phase III

June 28, 1996

SomatoKine covered under U.S. patent

June 28, 1996

Apolipoprotein B synthesis inhibitors reported

June 28, 1996

Phase III trial for Fortical approved in U.K.

June 28, 1996

C31G research results reported

June 21, 1996

Caverject cleared for marketing in Canada

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...